Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M; JPAS Study Group. Fujii Y, et al. Among authors: inagaki n. J Hum Hypertens. 2020 Jan;34(1):34-42. doi: 10.1038/s41371-019-0229-4. Epub 2019 Aug 28. J Hum Hypertens. 2020. PMID: 31462725
Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.
Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M. Umakoshi H, et al. Among authors: inagaki n. Clin Endocrinol (Oxf). 2015 Oct;83(4):462-7. doi: 10.1111/cen.12761. Epub 2015 Mar 16. Clin Endocrinol (Oxf). 2015. PMID: 25727719
Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.
Ueda-Sakane Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, Yasuno S, Miura M, Sone M, Yasoda A, Okada T, Togashi K, Nakao K, Inagaki N. Ueda-Sakane Y, et al. Among authors: inagaki n. Endocr J. 2016 Aug 31;63(8):703-14. doi: 10.1507/endocrj.EJ16-0038. Epub 2016 Jun 5. Endocr J. 2016. PMID: 27263854 Free article.
Regulation of type 1 iodothyronine deiodinase by LXRα.
Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N. Sakane Y, et al. Among authors: inagaki n. PLoS One. 2017 Jun 15;12(6):e0179213. doi: 10.1371/journal.pone.0179213. eCollection 2017. PLoS One. 2017. PMID: 28617824 Free PMC article.
Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism.
Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group. Umakoshi H, et al. Among authors: inagaki n. J Clin Endocrinol Metab. 2018 Mar 1;103(3):900-908. doi: 10.1210/jc.2017-01774. J Clin Endocrinol Metab. 2018. PMID: 29092077
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group. Ohno Y, et al. Among authors: inagaki n. Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22. Hypertension. 2018. PMID: 29358460
988 results